Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy
Authors
Keywords
-
Journal
CANCER IMAGING
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1186/s40644-023-00630-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global burden of oesophageal and gastric cancer by histology and subsite in 2018
- (2020) Melina Arnold et al. GUT
- Definitive Chemoradiotherapy Versus Trimodality Therapy for Resectable Oesophageal Carcinoma: Meta-analyses and Systematic Review of Literature
- (2019) Daan M. Voeten et al. WORLD JOURNAL OF SURGERY
- Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation
- (2019) Yimin Li et al. Radiation Oncology
- Prognostic value of 18F-FDG PET/MR imaging biomarkers in oesophageal squamous cell carcinoma
- (2019) Chih-Wei Yu et al. EUROPEAN JOURNAL OF RADIOLOGY
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction
- (2018) Mohamed Belmouhand et al. Abdominal Radiology
- Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer
- (2017) Kee H. Wong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Interim 18 F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review
- (2017) Marta Cremonesi et al. RADIOTHERAPY AND ONCOLOGY
- Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation
- (2016) Shu-Hang Ng et al. EUROPEAN RADIOLOGY
- Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy
- (2016) Sophie E. Heethuis et al. RADIOTHERAPY AND ONCOLOGY
- Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer
- (2015) C. Yip et al. DISEASES OF THE ESOPHAGUS
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
- (2015) Joel Shapiro et al. LANCET ONCOLOGY
- Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer
- (2015) Peter S.N. van Rossum et al. RADIOTHERAPY AND ONCOLOGY
- The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)
- (2013) Odré Palie et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Primary Colorectal Cancer: Use of Kinetic Modeling of Dynamic Contrast-enhanced CT Data to Predict Clinical Outcome
- (2013) Tong San Koh et al. RADIOLOGY
- Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization
- (2012) Yu-Chun Lin et al. MAGNETIC RESONANCE IN MEDICINE
- Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer
- (2011) Mark van Heijl et al. ANNALS OF SURGERY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now